— Know what they know.
Not Investment Advice
Also trades as: 0IIM.L (LSE) · $vol 0M

ESPR NASDAQ

Esperion Therapeutics, Inc.
1W: +0.3% 1M: +58.9% 3M: -10.1% YTD: -15.6% 1Y: +244.4% 3Y: +84.1% 5Y: -86.3%
$3.13
+0.00 (+0.00%)
 
Weekly Expected Move ±28.1%
$1 $2 $3 $4 $5
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 62 · $650.8M mcap · 208M float · 5.32% daily turnover · Short 33% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
46.1 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: 76.6%
Cost Advantage
63
Intangibles
22
Switching Cost
55
Network Effect
68
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ESPR shows a Weak competitive edge (46.1/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Network Effects. ROIC of 76.6% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$3
Low
$3
Avg Target
$5
High
Based on 6 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 8Hold: 15Sell: 2Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$3.19
Analysts4
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-01 Jefferies Initiated $3 +5.5% $3.11
2026-05-01 Piper Sandler $9 $3 -6 +1.6% $3.11
2026-05-01 H.C. Wainwright Initiated $3 +1.5% $3.11
2026-05-01 Cantor Fitzgerald $9 $3 -6 +58.0% $2.00
2025-11-24 Piper Sandler Initiated $9 +183.9% $3.17
2025-09-25 Cantor Fitzgerald Kristen Kluska $8 $9 +1 +251.6% $2.56
2024-12-17 Cantor Fitzgerald Kristen Kluska Initiated $8 +163.2% $3.04
2022-05-03 Needham Serge Belanger Initiated $12 +83.8% $6.53
2021-05-03 Wells Fargo Derek Archila Initiated $20 -21.8% $25.59

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
May 22, 2026
DCF
1
ROE
3
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ESPR receives an overall rating of C-. Areas of concern: DCF (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-03-10 D+ C-
2026-03-10 C D+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

33 Grade D
Profitability
17
Balance Sheet
32
Earnings Quality
52
Growth
88
Value
23
Momentum
80
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ESPR scores highest in Growth (88/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-3.24
Distress Zone
Piotroski F-Score
4/9
Beneish M-Score
1567.29
Possible Manipulator
Ohlson O-Score
-0.79
Bankruptcy prob: 31.3%
Moderate
Credit Rating
CCC
Score: 12.3/100
Trend: Deteriorating
Earnings Quality
OCF/NI: 2.45x
Accruals: 2.7%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ESPR scores -3.24, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ESPR scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ESPR's score of 1567.29 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ESPR's implied 31.3% bankruptcy probability is elevated and warrants attention to the balance sheet. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ESPR receives an estimated rating of CCC (score: 12.3/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-105.99x
PEG
-0.32x
P/S
1.56x
P/B
-2.55x
P/FCF
-37.87x
P/OCF
EV/EBITDA
13.85x
EV/Revenue
2.56x
EV/EBIT
13.86x
EV/FCF
-58.77x
Earnings Yield
-1.08%
FCF Yield
-2.64%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. ESPR currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.330
NI / EBT
×
Interest Burden
-0.072
EBT / EBIT
×
EBIT Margin
0.184
EBIT / Rev
×
Asset Turnover
1.033
Rev / Assets
×
Equity Multiplier
-1.172
Assets / Equity
=
ROE
2.1%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ESPR's ROE of 2.1% is driven by Asset Turnover (1.033), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.33 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$3.13
Median 1Y
$1.49
5th Pctile
$0.33
95th Pctile
$6.85
Ann. Volatility
87.3%
Analyst Target
$3.19
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Sheldon L. Koenig
President and Chief Executive Officer
$770,833 $1,260,000 $3,535,512
John B. Harlow,
Jr. Chief Commercial Officer
$66,875 $1,608,991 $2,813,103
Benjamin Halladay
Chief Financial Officer
$495,833 $357,000 $1,351,935

CEO Pay Ratio

320:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $3,535,512
Avg Employee Cost (SGA/emp): $11,052
Employees: 15,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
15,000
+4834.2% YoY
Revenue / Employee
$26,876
Rev: $403,135,000
Profit / Employee
$-1,512
NI: $-22,682,000
SGA / Employee
$11,052
Avg labor cost proxy
R&D / Employee
$3,190
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 8.5% 8.1% 1.8% 1.6% 1.8% 1.7% 89.7% 91.7% 85.4% 80.0% 53.7% 22.2% 25.3% 22.3% 12.3% 36.3% 24.7% 25.1% 6.6% 2.1% 2.15%
ROA -1.1% -1.1% -73.2% -63.9% -70.1% -66.2% -74.2% -75.8% -70.6% -66.2% -92.2% -38.1% -43.4% -38.2% -18.8% -55.8% -37.9% -38.5% -5.6% -1.8% -1.83%
ROIC 1.1% 97.7% 91.3% 75.3% 83.3% 77.6% 61.7% 63.7% 58.4% 53.6% -33.2% -7.4% 1.1% 3.5% 74.4% -54.7% -48.5% -40.2% 60.9% 76.6% 76.58%
ROCE -1.1% -1.0% -72.3% -59.2% -65.6% -60.8% -1.1% -1.2% -1.1% -96.5% -3.0% -56.3% -82.1% -58.3% 7.7% -90.8% -33.4% -28.1% 38.0% 46.7% 46.72%
Gross Margin 95.6% 61.4% 67.0% 62.2% 51.3% 65.7% 77.9% 52.1% 73.7% 60.6% 64.5% 92.7% 78.9% 66.5% 62.9% 51.5% 65.4% 36.5% 83.5% 56.8% 56.84%
Operating Margin -80.0% -3.9% -3.6% -2.3% -2.8% -2.2% -2.3% -2.0% -1.4% -81.1% -1.3% 52.5% 3.5% -31.0% -6.4% -34.0% 8.6% -11.4% 50.6% -8.2% -8.22%
Net Margin -1.1% -4.8% -4.2% -3.0% -3.5% -2.9% -2.9% -2.5% -1.9% -1.2% -1.7% 44.3% -83.9% -57.2% -30.8% -62.2% -15.4% -35.9% 36.7% -31.5% -31.45%
EBITDA Margin -79.6% -3.9% -3.3% -2.3% -2.8% -2.2% -2.2% -1.9% -1.4% -77.2% -1.3% 54.5% -65.3% -27.9% -7.0% -32.3% 9.5% -10.6% 50.6% -8.2% -8.22%
FCF Margin -4.7% -3.8% -3.4% -2.4% -3.2% -2.6% -2.3% -2.3% -1.9% -1.4% -1.2% -11.9% -3.6% -8.8% -7.2% -38.7% -46.4% -30.7% -3.2% -4.3% -4.35%
OCF Margin -4.7% -3.8% -3.4% -2.4% -3.2% -2.6% -2.3% -2.3% -1.9% -1.4% -1.2% -11.9% -3.5% -8.7% -7.1% -38.6% -46.4% -30.7% -3.2% -4.3% -4.35%
ROA 3Y Avg snapshot only -29.40%
ROIC Economic snapshot only 25.19%
Cash ROA snapshot only -3.90%
Cash ROIC snapshot only -23.26%
CROIC snapshot only -23.26%
NOPAT Margin snapshot only 14.32%
Pretax Margin snapshot only -1.33%
R&D / Revenue snapshot only 10.59%
SGA / Revenue snapshot only 39.67%
SBC / Revenue snapshot only 1.77%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -1.71 -1.03 -0.68 -1.20 -1.56 -1.87 -1.96 -0.52 -0.68 -0.53 -1.61 -5.88 -4.26 -3.71 -8.31 -1.84 -1.86 -4.96 -46.42 -92.78 -105.986
P/S Ratio 8.93 4.39 2.35 3.17 5.96 6.30 6.07 1.54 1.73 1.07 2.89 2.21 1.51 1.09 1.29 1.09 0.72 1.73 2.61 1.65 1.556
P/B Ratio -5.77 -3.32 -0.94 -1.44 -2.04 -2.31 -1.41 -0.39 -0.47 -0.34 -0.74 -1.12 -0.92 -0.71 -1.11 -0.73 -0.50 -1.35 -3.49 -2.28 -2.555
P/FCF -1.90 -1.16 -0.70 -1.32 -1.86 -2.39 -2.62 -0.66 -0.92 -0.78 -2.48 -18.57 -42.30 -12.34 -17.95 -2.81 -1.56 -5.63 -81.60 -37.87 -37.868
P/OCF
EV/EBITDA -1.50 -0.75 -0.83 -1.56 -2.00 -2.44 -3.13 -1.21 -1.49 -1.36 -5.29 -34.82 -21.61 -27.09 115.20 -8.24 -19.70 -35.54 22.83 13.85 13.848
EV/Revenue 7.01 2.74 2.36 3.18 5.97 6.32 7.31 2.70 2.80 1.98 6.83 4.21 3.16 2.64 2.64 2.81 2.39 3.20 3.55 2.56 2.556
EV/EBIT -1.49 -0.75 -0.83 -1.55 -1.99 -2.43 -3.12 -1.21 -1.49 -1.36 -5.29 -34.66 -21.57 -27.02 116.80 -8.23 -19.64 -35.41 22.86 13.86 13.858
EV/FCF -1.49 -0.72 -0.70 -1.33 -1.86 -2.39 -3.16 -1.15 -1.50 -1.45 -5.87 -35.32 -88.60 -29.93 -36.57 -7.26 -5.14 -10.41 -111.06 -58.77 -58.770
Earnings Yield -58.5% -96.8% -1.5% -83.1% -64.0% -53.6% -51.0% -1.9% -1.5% -1.9% -62.3% -17.0% -23.5% -27.0% -12.0% -54.3% -53.7% -20.2% -2.2% -1.1% -1.08%
FCF Yield -52.7% -86.2% -1.4% -75.6% -53.8% -41.9% -38.2% -1.5% -1.1% -1.3% -40.3% -5.4% -2.4% -8.1% -5.6% -35.5% -64.2% -17.8% -1.2% -2.6% -2.64%
EV/Gross Profit snapshot only 3.932
Acquirers Multiple snapshot only 14.103
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 3.68 3.68 4.48 4.48 4.48 4.48 2.67 2.67 2.67 2.67 1.29 1.29 1.29 1.29 1.37 1.37 1.37 1.37 0.56 0.56 0.558
Quick Ratio 3.51 3.51 4.02 4.02 4.02 4.02 2.29 2.29 2.29 2.29 0.87 0.87 0.87 0.87 0.99 0.99 0.99 0.99 0.21 0.21 0.209
Debt/Equity -1.93 -1.93 -1.32 -1.32 -1.32 -1.32 -0.81 -0.81 -0.81 -0.81 -1.19 -1.19 -1.19 -1.19 -1.52 -1.52 -1.52 -1.52 -1.81 -1.81 -1.815
Net Debt/Equity
Debt/Assets 0.52 0.52 0.68 0.68 0.68 0.68 1.05 1.05 1.05 1.05 2.63 2.63 2.63 2.63 1.72 1.72 1.72 1.72 1.18 1.18 1.176
Debt/EBITDA -0.64 -0.70 -1.17 -1.43 -1.29 -1.39 -1.48 -1.44 -1.59 -1.74 -3.60 -19.48 -13.32 -18.78 77.69 -6.68 -18.19 -21.63 8.73 7.10 7.100
Net Debt/EBITDA 0.41 0.45 -0.00 -0.00 -0.00 -0.00 -0.53 -0.52 -0.57 -0.63 -3.06 -16.52 -11.29 -15.93 58.67 -5.05 -13.74 -16.33 6.06 4.93 4.925
Interest Coverage -8.80 -6.37 -4.81 -3.49 -3.65 -3.35 -3.11 -3.18 -2.87 -2.58 -2.55 -0.48 -0.70 -0.50 0.13 -1.37 -0.46 -0.35 0.74 1.70 1.700
Equity Multiplier -3.67 -3.67 -1.94 -1.94 -1.94 -1.94 -0.77 -0.77 -0.77 -0.77 -0.45 -0.45 -0.45 -0.45 -0.88 -0.88 -0.88 -0.88 -1.54 -1.54 -1.543
Cash Ratio snapshot only 0.558
Debt Service Coverage snapshot only 1.701
Cash to Debt snapshot only 0.306
FCF to Debt snapshot only -0.033
Defensive Interval snapshot only 573.5 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.22 0.26 0.21 0.24 0.18 0.20 0.24 0.26 0.28 0.33 0.51 1.01 1.22 1.30 1.21 0.94 0.98 1.11 1.00 1.03 1.033
Inventory Turnover 0.69 1.34 0.56 0.77 1.07 1.10 0.77 0.91 0.84 1.03 0.86 0.83 1.00 1.08 0.86 1.12 1.29 1.76 1.44 1.47 1.467
Receivables Turnover 10.03 11.73 4.44 5.06 3.82 4.08 2.66 2.86 3.10 3.63 2.83 5.59 6.76 7.19 5.17 4.04 4.17 4.72 3.66 3.80 3.796
Payables Turnover 0.14 0.27 0.41 0.56 0.77 0.80 1.33 1.55 1.43 1.77 1.58 1.52 1.84 1.99 1.65 2.16 2.47 3.39 2.46 2.51 2.508
DSO 36 31 82 72 96 89 137 128 118 100 129 65 54 51 71 90 88 77 100 96 96.1 days
DIO 531 272 649 472 342 331 471 403 436 353 425 441 364 338 426 324 284 207 254 249 248.9 days
DPO 2659 1362 893 649 471 455 275 235 255 206 231 240 198 184 222 169 148 108 149 146 145.5 days
Cash Conversion Cycle -2092 -1059 -162 -105 -33 -35 333 296 299 248 323 267 220 205 275 246 224 177 205 199 199.5 days
Fixed Asset Turnover snapshot only 128.296
Operating Cycle snapshot only 345.0 days
Cash Velocity snapshot only 2.492
Capital Intensity snapshot only 1.114
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue -71.3% -66.8% -65.5% -61.8% 8.7% -0.9% -3.8% -9.3% 30.3% 42.8% 54.1% 1.8% 2.2% 1.9% 1.9% 13.0% -3.5% 2.8% 21.3% 61.1% 61.13%
Net Income -2.9% -2.1% -87.5% -50.4% 20.6% 21.1% 13.2% -1.6% 13.7% 14.3% 10.4% 63.8% 55.7% 58.4% 75.3% -77.1% -5.6% -22.0% 56.2% 95.2% 95.16%
EPS -3.3% -2.2% -36.8% 35.9% 67.1% 69.2% 56.5% 21.1% 50.1% 48.1% 41.5% 85.0% 74.4% 76.1% 85.8% -71.3% -1.3% -20.0% 69.9% 96.2% 96.22%
FCF -6.4% -3.1% -2.1% -1.0% 26.0% 30.8% 33.7% 11.0% 24.0% 26.1% 22.5% 85.6% 94.0% 81.5% 82.3% -2.7% -11.6% -2.6% 46.2% 81.9% 81.88%
EBITDA -3.4% -2.2% -84.6% -41.1% 30.7% 29.8% 20.6% 0.5% 18.4% 19.8% 14.9% 84.7% 75.3% 80.8% 1.1% -2.2% 20.0% 5.1% 7.2% 1.9% 1.87%
Op. Income -3.2% -2.1% -86.8% -44.0% 29.1% 27.8% 20.8% 1.0% 17.9% 19.2% 13.3% 81.3% 1.0% 1.1% 1.3% -15.2% -8.2% -2.8% 10.8% 2.9% 2.90%
OCF Growth snapshot only 81.83%
Asset Growth snapshot only 35.50%
Debt Growth snapshot only -7.31%
Shares Change snapshot only 28.16%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y -24.8% -35.3% -41.1% -39.9% -20.2% 1.6% -25.9% -22.2% -20.0% -0.6% 64.8% 59.6% 61.8% 42.7% 58.4% 61.5% 74.8% 72.9% 72.86%
Revenue 5Y -8.8% -7.0% -3.4% -2.3% 17.5% 1.2% 4.4% 6.8% 12.1% 12.3% 12.35%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 70.4% -23.0% -35.4% -32.7% -23.1% -28.1% -31.3% -6.4% 59.0% 57.4% 60.1% 34.4% 59.7% 54.4% 75.0% 76.5% 76.46%
Gross Profit 5Y 41.3% 4.2% 8.6% 10.7% 5.0% -2.0% 2.9% 3.4% 3.44%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 8.3% 8.3% 38.6% 38.6% 38.6% 38.6% 5.0% 5.0% 5.0% 5.0% -16.5% -16.5% -16.5% -16.5% -3.4% -3.4% -3.4% -3.4% 23.4% 23.4% 23.40%
Assets 5Y 3.6% 3.6% 9.2% 9.2% 9.2% 9.2% -2.3% -2.3% -2.3% -2.3% 7.5% 7.5% 7.5% 7.5% 9.9% 9.9% 9.9% 9.9% 5.7% 5.7% 5.69%
Equity 3Y
Book Value 3Y
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.17 0.19 0.22 0.04 0.00 0.00 0.08 0.20 0.03 0.06 0.42 0.36 0.06 0.04 0.25 0.88 0.14 0.20 0.33 0.37 0.367
Earnings Stability 0.36 0.35 0.36 0.34 0.35 0.28 0.25 0.29 0.31 0.26 0.24 0.00 0.05 0.02 0.00 0.35 0.11 0.16 0.46 0.47 0.472
Margin Stability 0.64 0.67 0.00 0.00 0.70 0.71 0.08 0.00 0.79 0.84 0.45 0.73 0.74 0.75 0.23 0.00 0.86 0.82 0.79 0.79 0.790
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.00 1.00 0.50 0.50 0.50 1.00 1.00 1.00 1.00 0.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.00 1.00 1.00 1.00 0.50 1.00 1.00 1.00 0.00 0.00 0.00 1.00 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.50 0.50 0.92 0.92 0.95 0.99 0.95 0.94 0.96 0.50 0.50 0.50 0.50 0.50 0.98 0.91 0.50 0.50 0.500
Earnings Smoothness
ROE Trend
Gross Margin Trend 0.38 0.22 0.42 13.30 -0.15 -0.22 -0.26 -0.27 -0.09 -0.08 -0.10 0.12 0.18 0.18 0.16 -0.06 -0.13 -0.20 -0.07 -0.09 -0.086
FCF Margin Trend -4.57 -3.55 -2.93 22.11 -0.76 -0.60 -0.45 -0.93 2.09 1.84 1.67 2.25 2.50 1.92 1.67 0.85 0.49 0.42 0.59 0.21 0.209
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.90 0.89 0.98 0.91 0.84 0.78 0.75 0.80 0.74 0.68 0.65 0.32 0.10 0.30 0.46 0.65 1.20 0.88 0.58 2.45 2.450
FCF/OCF 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.02 1.01 1.01 1.00 1.00 1.00 0.99 1.00 1.000
FCF/Net Income snapshot only 2.450
OCF/EBITDA snapshot only -0.236
CapEx/Revenue 0.1% 0.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.1% 0.1% 0.0% 0.0% 0.0% 0.00%
CapEx/Depreciation snapshot only 0.000
Accruals Ratio -0.11 -0.12 -0.01 -0.06 -0.11 -0.14 -0.19 -0.15 -0.18 -0.22 -0.33 -0.26 -0.39 -0.27 -0.10 -0.19 0.07 -0.05 -0.02 0.03 0.027
Sloan Accruals snapshot only -0.555
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 9.9% 17.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 9.1% 14.9% -1.2% -77.6% -59.5% -62.5% -19.8% -1.2% -84.0% -72.0% -19.6% -21.6% -27.3% -35.8% -24.6% -3.4% -1.7% -0.5% -8.3% -15.1% -15.09%
Total Shareholder Return 9.1% 14.9% -1.2% -77.6% -59.5% -62.5% -19.8% -1.2% -84.0% -72.0% -19.6% -21.6% -27.3% -35.8% -24.6% -3.4% -1.7% -0.5% -8.3% -15.1% -15.09%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.09 1.33 1.330
Interest Burden (EBT/EBIT) 1.11 1.16 1.21 1.29 1.27 1.30 1.32 1.31 1.35 1.39 1.39 3.10 2.42 3.00 -6.89 1.73 3.19 3.86 -0.33 -0.07 -0.072
EBIT Margin -4.69 -3.67 -2.84 -2.04 -3.00 -2.60 -2.34 -2.24 -1.88 -1.46 -1.29 -0.12 -0.15 -0.10 0.02 -0.34 -0.12 -0.09 0.16 0.18 0.184
Asset Turnover 0.22 0.26 0.21 0.24 0.18 0.20 0.24 0.26 0.28 0.33 0.51 1.01 1.22 1.30 1.21 0.94 0.98 1.11 1.00 1.03 1.033
Equity Multiplier -7.45 -7.45 -2.51 -2.51 -2.51 -2.51 -1.21 -1.21 -1.21 -1.21 -0.58 -0.58 -0.58 -0.58 -0.65 -0.65 -0.65 -0.65 -1.17 -1.17 -1.172
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-12.37 $-11.66 $-7.30 $-3.85 $-4.07 $-3.59 $-3.18 $-3.04 $-2.03 $-1.86 $-1.86 $-0.46 $-0.52 $-0.45 $-0.26 $-0.78 $-0.53 $-0.53 $-0.08 $-0.03 $-0.03
Book Value/Share $-3.67 $-3.63 $-5.35 $-3.23 $-3.11 $-2.90 $-4.41 $-4.13 $-2.96 $-2.89 $-4.05 $-2.40 $-2.41 $-2.33 $-1.99 $-1.98 $-1.97 $-1.96 $-1.06 $-1.20 $-1.23
Tangible Book/Share $-3.67 $-3.64 $-5.35 $-3.23 $-3.12 $-2.91 $-4.41 $-4.13 $-2.96 $-2.89 $-4.05 $-2.40 $-2.41 $-2.33 $-1.99 $-1.98 $-1.98 $-1.96 $-1.06 $-1.20 $-1.20
Revenue/Share $2.37 $2.75 $2.13 $1.47 $1.07 $1.06 $1.03 $1.03 $0.80 $0.92 $1.03 $1.21 $1.47 $1.52 $1.70 $1.32 $1.36 $1.53 $1.42 $1.66 $1.66
FCF/Share $-11.14 $-10.39 $-7.16 $-3.51 $-3.42 $-2.81 $-2.38 $-2.42 $-1.50 $-1.26 $-1.21 $-0.14 $-0.05 $-0.13 $-0.12 $-0.51 $-0.63 $-0.47 $-0.05 $-0.07 $-0.07
OCF/Share $-11.14 $-10.38 $-7.16 $-3.51 $-3.42 $-2.81 $-2.38 $-2.42 $-1.50 $-1.26 $-1.21 $-0.14 $-0.05 $-0.13 $-0.12 $-0.51 $-0.63 $-0.47 $-0.05 $-0.07 $-0.07
Cash/Share $11.63 $11.53 $7.04 $4.25 $4.10 $3.82 $2.27 $2.13 $1.53 $1.49 $0.73 $0.43 $0.44 $0.42 $0.74 $0.74 $0.74 $0.73 $0.59 $0.67 $0.62
EBITDA/Share $-11.09 $-10.05 $-6.03 $-2.99 $-3.19 $-2.76 $-2.40 $-2.31 $-1.51 $-1.34 $-1.34 $-0.15 $-0.22 $-0.15 $0.04 $-0.45 $-0.17 $-0.14 $0.22 $0.31 $0.31
Debt/Share $7.07 $7.01 $7.06 $4.27 $4.12 $3.84 $3.55 $3.33 $2.39 $2.33 $4.81 $2.85 $2.87 $2.78 $3.02 $3.01 $3.00 $2.98 $1.93 $2.18 $2.18
Net Debt/Share $-4.56 $-4.52 $0.02 $0.01 $0.01 $0.01 $1.28 $1.20 $0.86 $0.84 $4.08 $2.42 $2.43 $2.35 $2.28 $2.28 $2.27 $2.25 $1.34 $1.51 $1.51
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score -3.240
Altman Z-Prime snapshot only -11.180
Piotroski F-Score 4 4 3 3 5 5 3 2 3 2 3 4 4 4 5 3 3 4 5 4 4
Beneish M-Score -4.34 -0.09 332.29 332.47 333.61 331.51 -3.77 -3.44 -3.89 -3.71 -3.56 -0.44 -3.22 -3.45 -1.96 -1.18 -1.55 -1.59 1567.50 1567.29 1567.291
Ohlson O-Score snapshot only -0.788
Net-Net WC snapshot only $-2.39
EVA snapshot only $52054220.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only CCC
Credit Score 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 12.80 19.99 19.91 20.00 7.93 12.26 12.265
Credit Grade snapshot only 17
Credit Trend snapshot only -7.724
Implied Spread (bps) snapshot only 1200.000
Industry Credit Rank snapshot only 0
Sector Credit Rank snapshot only 0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms